Dimensional Changes of Peri-implant Tissue in Immediate Implants With Individualized Healing Abut… (NCT06455436) | Clinical Trial Compass
RecruitingNot Applicable
Dimensional Changes of Peri-implant Tissue in Immediate Implants With Individualized Healing Abutments
Spain32 participantsStarted 2024-05-08
Plain-language summary
The loss of a tooth leads to a series of biological changes in the tissues, resulting in bone resorption and gingival collapse. To avoid these problems, it has been proposed to place immediate post-extraction implants, allowing a reduction in treatment time and the number of surgeries, as well as better maintenance of the tissues. This technique can be performed with standard abutments after implant placement or, more recently, the use of temporary abutments has been proposed.
Who can participate
Age range
25 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patient ( 25 years old).
* Need for extraction of an irrational tooth to be treated in the molar/premolar position of the upper/lower arch.
* Presence of 2mm of keratinized gingiva.
* Bone dehiscence in the alveolar walls of 2 mm. 2 mm.
* Adequate amount of bone in the interradicular septum to stabilize the implant (minimum height 10 mm, minimum width 4 mm at the base of the septum).
* Plaque index (FMSPI, full mouth score plaque index) \< 10%.
* Non-smokers or smokers of less than 10 cigarettes per day.
* Absence of systemic diseases that contraindicate implant surgery.
Exclusion Criteria:
* Presence of alveoli with dehiscence \>2mm.
* Presence of adjacent implants.
* \< 2mm of keratinized gingiva.
* Presence of active infection (fistula, suppuration) at the extraction site.
* Presence of apical granuloma \>2mm in diameter in the root(s) of the tooth or teeth to be extracted.
* Residual bone apical to the extraction insufficient to anchor the implant.
* Pregnant or lactating women.
* Severe cognitive or psychiatric disorders.
* Compromised general health status ( ASA IV).
* Use of drugs that alter bone metabolism and healing.
* Absence of manual primary stability of the implant
* Bone dehiscence or fenestration after implant placement (manual rotation).
* Gap 2mm between the implant and the vestibular bone wall.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.